ITUS Corporation is an early cancer detection technology company currently developing a platform called Cchek, a series of inexpensive, non-invasive blood tests for the early detection of cancer. Specifically, the test will be able to detect early-stage solid tumor based cancer. This is based on the body’s immunological response to…
Browsing: Ideas & Technologies
CytRx Corporation is a clinical-stage, biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. CytRx’s initial focus is on seeking regulatory approval for and commercialization of it’s lead drug candidate, aldoxorubicin, an improved version of the widely used chemotherapeutic agent doxorubicin. Aldoxorubicin is currently in…
Numerous global public and private initiatives are underway offering exceptional opportunity to revolutionize healthcare delivery. More advanced diagnostic techniques, based on individual patient characteristics including biomarker identification, evidence-based medicine, and a quality over cost time approach are its centerpiece. Personalizing the development of diagnostics and therapeutics, as well as monitoring disease…
Creatv MicroTech is a company that understands that cancer will, at some point, likely touch us, our families and friends. In the U.S. alone, 43% of men and 38% of women will develop cancer in their lifetimes. Cancer detected early at curable stage can result in high probability of long…
CivaTech Oncology, Inc. (“CivaTech” or the “Company”) has developed a major technological advance in the radiation treatment of cancerous tumors. CivaTech products significantly reduce the side effects experienced from traditional implantable radiation sources or external beam methods while providing meaningfully higher doses of radiation not previously possible without irreversible damage…
Valisure is a start-up company founded in 2015 in New Haven, CT by a group of Yale and Harvard alumni with proven biotech industry success (recent exit: Ion Torrent $725M). Valisure’s disruptive technology in the pharmaceutical analysis space has broad application but the team has focused on the rapidly growing…
CancerVacs is developing intralymphnode immunotherapeutics for certain metastatic cancer patients with no therapeutic options. This includes disseminated follicular lymphoma, glioblastoma multiforme, metastatic castrate-resistant prostate carcinoma, malignant melanoma, or other metastatic solid tumor. CancerVacs utilizes a patients’ lymphatic system, especially lymphnodes, as bioreactors that retrain cancer patients’ own immune cells to…
Promaxo, a medical device startup focusing on portable MRI and other technology, is developing and commercializing an office-based, portable MRI with cellular level spatial resolution. Also in development is a real time biopsy and other treatment tools for the urology market. The company’s current focus is on prostate cancer disease…